Teva Pharmaceutical Industries Ltd. — Earnings Release 2006

Nov 7, 2006

_________

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.2529Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267297 , 03-9267281 Fax: 03-9267429E.mail address: Liraz.Kalif@Teva.co.ilDate of transmission: 07/11/2006              Time of broadcast: 14:55 14:28:20

Reference: 2006-02-127303

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Teva Reports third quarter 2006 results
Q306E071106combinedfinal_isa.pdf

Please find attached a press release announced today in the U.S. and its unofficial hebrew translation. The binding release is the english version.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 31/10/2006
- - -
Name of the Signatory: : Suesskind Dan , , Position of Signatory in the reporting corporation: Chief Financial Officer
Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: dan.suesskind@teva.co.il